Rising dollar
(Stock image)

After a week full of losing sessions, Canada’s main stock index managed to regain some ground on Friday. The energy sector was the only laggard while industrials led in gains.

U.S. markets rallied after the Commerce Department’s Bureau of Economic Analysis reported that the personal consumption expenditures price index rose 0.1 per cent in June after being unchanged in May. In the 12 months through June, the index climbed 2.5 per cent after rising 2.6 per cent in May. Seen as a sign that inflation is continuing to ease from its four-decade high, this fuelled hope among investors that the U.S. Federal Reserve may continue to cut interest rates.

TSX22,814.81+206.78TSX
TSXV579.33+5.69TSXV
CSE165.21+1.22CSE
DJIA40,589.34+654.27DJIA
NASDAQ17,357.88+176.16NASDAQ
S&P 5005,463.38+64.16S&P 500

The Canadian dollar traded for 72.28 cents U.S. compared to 72.35 cents U.S. on Thursday.

U.S. crude futures traded $1.51 lower at $76.77 a barrel, and the Brent contract lost $1.58 to $80.79 a barrel.

The price of gold was up US$22.82 to US$2,412.51.

In world markets, the Nikkei was down 202.10 points to 37,667.41, the Hang Seng was up 16.34 points to 17,021.31, the FTSE was up 99.36 points to 8,285.71, and the DAX was up 124.50 points to 18,423.22.

The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.

(Top image: File.)


More From The Market Online
Air Canada airliner

Air Canada negotiates new labour deal with pilots, avoids shutdown

Air Canada (TSX:AC) and the union representing thousands of its pilots negotiated a new labour deal and averted a nationwide shutdown.
Tudor Gold 2020 drilling at Treaty Creek.

Tudor Gold to advance Treaty Creek Project with Fuse Advisors

Tudor Gold (TSXV:TUD) enters into an agreement with Fuse Advisors to advance the Treaty Creek Project in British Columbia's Golden Triangle.
U.S. Food and Drug website in browser with logo

FDA extends review period for Medexus’ treosulfan to 2025

Medexus Pharmaceuticals (TSX:MDP) reveals the U.S. FDA has extended the review period for the company's new drug application for treosulfan.
King's Cross station in London

AtkinsRéalis boosts long-term revenue with U.K. rail contract

AtkinsRéalis Group (TSX:ATRL) will modernize the U.K.'s rail signalling infrastructure over the next decade.